09/18/2026
When evaluating the future direction of U.S. medical device oversight, patient safety, and clinical trial innovation, all eyes look to the center driving national policy.
We are honored to welcome Michelle Tarver, MD, PhD, Director of the FDA’s Center for Devices and Radiological Health (CDRH), as a featured presenter at the BEST Clinical & Regulatory Practices Conference.
As Director of CDRH, Dr. Tarver leads the agency center responsible for ensuring that patients and providers in the United States have timely access to safe, effective medical devices. A clinician-scientist with a doctorate in epidemiology from Johns Hopkins, her career across FDA leadership has focused on advancing patient-centered trial design, robust evidence generation, and modern regulatory science pathways.
At this year’s conference, Dr. Tarver will present a key address:
📋 “US Perspective on Medical Device Clinical Investigations”
Her extensive institutional leadership centers on critical themes facing today's medtech innovators:
🔹 National Regulatory Strategy: The broader landscape and FDA priorities shaping U.S. medical device clinical investigations
🔹 Patient-Centered Evidence: The role of patient science, real-world evidence, and health equity in modern clinical trial design
🔹 Trial Optimization: Strategic frameworks for advancing novel technologies safely and efficiently across the total product life cycle
For clinical investigators, regulatory leaders, and medtech executives, attending this session offers a rare opportunity to hear directly from the executive leadership shaping the U.S. medical device landscape.
📅 October 26–27, 2026 | The Jacobs Institute (Buffalo, NY & Virtual)
🎟️ Explore the preliminary program & register: https://zurl.co/uF6Qs
